Foresite Capital Management IV’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,671,643
| Closed | -$25.7M | – | 5 |
|
|
2024
Q1 | $25.7M | Hold |
9,671,643
| – | – | 13% | 3 |
|
|
2023
Q4 | $22.9M | Hold |
9,671,643
| – | – | 11.58% | 3 |
|
|
2023
Q3 | $13.5M | Hold |
9,671,643
| – | – | 7.52% | 5 |
|
|
2023
Q2 | $29.3M | Hold |
9,671,643
| – | – | 14.41% | 3 |
|
|
2023
Q1 | $60.4M | Hold |
9,671,643
| – | – | 31.36% | 1 |
|
|
2022
Q4 | $59M | Hold |
9,671,643
| – | – | 25.2% | 1 |
|
|
2022
Q3 | $116M | Hold |
9,671,643
| – | – | 37.17% | 1 |
|
|
2022
Q2 | $122M | Hold |
9,671,643
| – | – | 32.84% | 1 |
|
|
2022
Q1 | $109M | Hold |
9,671,643
| – | – | 30.47% | 1 |
|
|
2021
Q4 | $171M | Hold |
9,671,643
| – | – | 35.26% | 1 |
|
|
2021
Q3 | $223M | Hold |
9,671,643
| – | – | 32.78% | 1 |
|
|
2021
Q2 | $225M | Hold |
9,671,643
| – | – | 30.43% | 1 |
|
|
2021
Q1 | $301M | Hold |
9,671,643
| – | – | 36.1% | 1 |
|
|
2020
Q4 | $385M | Buy |
+9,671,643
| New | +$385M | 41.79% | 1 |
|